Examination of B Cell Responses in Human Blood

Human Immune Responses Toward HIV-1 Envelope Antigens

NCT01344941 ·Status: COMPLETED

N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV

NCT04144335 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment

NCT03940521 ·Status: ACTIVE_NOT_RECRUITING

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants

NCT00039689 ·Status: RECRUITING

Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte Counts

NCT00001319 ·Status: COMPLETED

Analysis of Immune Responses to HIV Vaccines

NCT00068978 ·Status: COMPLETED

Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients

NCT00333892 ·Status: COMPLETED

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

NCT00001041 ·Status: COMPLETED ·Phase: PHASE1

Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil

NCT02236234 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure

NCT03758625 ·Status: COMPLETED ·Phase: PHASE1

A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients

NCT00000824 ·Status: TERMINATED ·Phase: NA

Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3

NCT00000756 ·Status: COMPLETED ·Phase: PHASE1

CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients

NCT01013415 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects

NCT01428596 ·Status: UNKNOWN ·Phase: PHASE1

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

NCT00002359 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications

NCT01909414 ·Status: WITHDRAWN ·Phase: PHASE1

Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer

NCT00968630 ·Status: COMPLETED ·Phase: PHASE2

An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

NCT00002172 ·Status: COMPLETED ·Phase: NA

Redirected MazF-CD4 Autologous T Cells for HIV Gene Therapy

NCT01787994 ·Status: COMPLETED ·Phase: PHASE1

Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old

NCT00814762 ·Status: COMPLETED ·Phase: PHASE1

Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects

NCT00623259 ·Status: COMPLETED ·Phase: PHASE1

Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts

NCT00951795 ·Status: WITHDRAWN

A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection

NCT05582694 ·Status: WITHDRAWN ·Phase: PHASE2

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

NCT00058734 ·Status: COMPLETED ·Phase: PHASE1

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

NCT00000721 ·Status: COMPLETED ·Phase: PHASE1